$1.13 Billion is the total value of 683 Capital Management, LLC's 144 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MUDS | New | MUDRICK CAP ACQUISITION CORP | $18,242,000 | – | 1,900,000 | +100.0% | 1.61% | – |
| NYRT | New | NEW YORK REIT INC | $16,132,000 | – | 749,999 | +100.0% | 1.43% | – |
| XLE | New | SELECT SECTOR SPDR TRput | $6,741,000 | – | 100,000 | +100.0% | 0.60% | – |
| MGNX | New | MACROGENICS INC | $6,290,000 | – | 250,000 | +100.0% | 0.56% | – |
| TIBRU | New | TIBERIUS ACQUISITION CORPunit 02/28/2021 | $4,542,000 | – | 450,000 | +100.0% | 0.40% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $4,030,000 | – | 283,230 | +100.0% | 0.36% | – |
| MGEN | New | MIRAGEN THERAPEUTICS INC | $3,505,000 | – | 500,000 | +100.0% | 0.31% | – |
| MDC | New | M D C HLDGS INCput | $2,792,000 | – | 100,000 | +100.0% | 0.25% | – |
| LACQ | New | LEISURE ACQUISITION CORP | $2,400,000 | – | 250,000 | +100.0% | 0.21% | – |
| OMAD | New | ONE MADISON CORP | $2,388,000 | – | 250,000 | +100.0% | 0.21% | – |
| GPAQ | New | GORDON POINTE ACQUISITION CO | $2,185,000 | – | 225,000 | +100.0% | 0.19% | – |
| LTNU | New | UNION ACQUISITION CORPunit 99/99/9999 | $2,046,000 | – | 200,000 | +100.0% | 0.18% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $1,924,000 | – | 195,285 | +100.0% | 0.17% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $1,842,000 | – | 600,000 | +100.0% | 0.16% | – |
| OPESU | New | OPES ACQUISITION CORPunit 03/07/2023 | $1,508,000 | – | 150,000 | +100.0% | 0.13% | – |
| HIIQ | New | HEALTH INS INNOVATIONS INC | $1,445,000 | – | 50,000 | +100.0% | 0.13% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $1,245,000 | – | 150,000 | +100.0% | 0.11% | – |
| MUDSW | New | MUDRICK CAP ACQUISITION CORP*w exp 02/12/202 | $1,235,000 | – | 1,900,000 | +100.0% | 0.11% | – |
| VBLT | New | VASCULAR BIOGENICS LTD | $920,000 | – | 400,000 | +100.0% | 0.08% | – |
| MTEC | New | MTECH ACQUISITION CORP | $719,000 | – | 75,000 | +100.0% | 0.06% | – |
| TDWWSB | New | TIDEWATER INC NEW*w exp 07/31/202 | $509,000 | – | 60,962 | +100.0% | 0.04% | – |
| CVONW | New | CONVERGEONE HLDGS INC*w exp 04/12/202 | $480,000 | – | 401,806 | +100.0% | 0.04% | – |
| SLNOW | New | SOLENO THERAPEUTICS INC*w exp 11/12/201 | $273,000 | – | 602,443 | +100.0% | 0.02% | – |
| ONTXW | New | ONCONOVA THERAPEUTICS INC*w exp 07/11/202 | $172,000 | – | 2,000,000 | +100.0% | 0.02% | – |
| LGCWS | New | LEGACY ACQUISITION CORP*w exp 11/30/202 | $175,000 | – | 500,000 | +100.0% | 0.02% | – |
| GPAQW | New | GORDON POINTE ACQUISITION CO*w exp 07/30/202 | $122,000 | – | 225,000 | +100.0% | 0.01% | – |
| LACQW | New | LEISURE ACQUISITION CORP*w exp 12/05/201 | $94,000 | – | 125,000 | +100.0% | 0.01% | – |
| GIGRT | New | GIGCAPITAL INCright 03/06/2020 | $76,000 | – | 200,000 | +100.0% | 0.01% | – |
| GIGWS | New | GIGCAPITAL INC*w exp 06/08/202 | $71,000 | – | 150,000 | +100.0% | 0.01% | – |
| BRPAR | New | BIG ROCK PARTNERS ACQUISI COright 12/01/2022 | $69,000 | – | 165,000 | +100.0% | 0.01% | – |
| MTECW | New | MTECH ACQUISITION CORP*w exp 08/01/202 | $47,000 | – | 75,000 | +100.0% | 0.00% | – |
| BRPAW | New | BIG ROCK PARTNERS ACQUISI CO*w exp 12/01/202 | $37,000 | – | 82,500 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IRSA INVERSIONES Y REP S A | 42 | Q3 2023 | 2.9% |
| CRESUD S A C I F Y A | 39 | Q3 2023 | 3.3% |
| ENOVA INTL INC | 34 | Q3 2023 | 8.2% |
| UNIQURE NV | 28 | Q3 2023 | 4.1% |
| INSPIRED ENTMT INC | 28 | Q3 2023 | 2.3% |
| MICRON TECHNOLOGY INC | 26 | Q1 2023 | 3.2% |
| GALMED PHARMACEUTICALS LTD | 25 | Q1 2020 | 1.2% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.9% |
| CARVANA CO | 24 | Q3 2023 | 14.2% |
| ALNYLAM PHARMACEUTICALS INC | 24 | Q2 2022 | 3.2% |
View 683 Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AxonPrime Infrastructure Acquisition Corp | February 14, 2023 | 441,138 | 2.9% |
| DIRTT ENVIRONMENTAL SOLUTIONS LTD | February 14, 2023 | 218,490 | - |
| Hawks Acquisition Corp | February 14, 2023 | 1,979,592 | 8.6% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2023 | 90,000 | 0.2% |
| SQZ Biotechnologies Co | February 14, 2023 | 1,330,889 | 4.5% |
| Trajectory Alpha Acquisition Corp. | February 14, 2023 | 1,484,799 | 8.6% |
| Concord Acquisition Corp | September 26, 2022 | 1,550,649 | 5.5% |
| Archer Aviation Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Hippo Holdings Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Joby Aviation, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View 683 Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View 683 Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.